Telix Pharmaceuticals TLX
NASDAQ TLX
$9.67 +0.64 (+7.09%)
At close: Nov 4, 2026 · 4:00 PM EST

Telix Pharmaceuticals (TLX) Ending Cash Balance (2023 - 2026)

Updated

Analysis

Telix Pharmaceuticals (TLX) Ending Cash Balance (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,333.71 Bn 1,307.33 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 665.21 Bn 585.07 Bn 17.30 Bn 16.91 Bn
3 AbbVie 521.27 Bn 489.32 Bn 13.12 Bn 10.77 Bn
4 Merck 370.99 Bn 325.42 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 314.75 Bn 288.32 Bn - -
6 Astrazeneca 293.18 Bn 267.16 Bn 13.26 Bn 7.94 Bn
7 Amgen 258.67 Bn 214.07 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 216.53 Bn 191.55 Bn 6.73 Bn 6.44 Bn
9 Pfizer 175.50 Bn 123.16 Bn 12.56 Bn 1.88 Bn
10 Telix Pharmaceuticals 3.28 Bn 2.24 Bn - 251.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 251.91 Mn
Dec 31, 2025 440.00 Mn
Dec 31, 2024 441.84 Mn
Dec 31, 2023 84.13 Mn
API Access

Telix Pharmaceuticals Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TLX&period=max&api_key=YOUR_API_KEY